| 序号 |
批准日期 |
商品名 |
活性成分 |
公司全称 |
注册审批号 |
规格 |
剂型/给药途径 |
参比药物 |
参比标准 |
市场状态 |
| 1 |
2024-06-28 |
ERIBULIN MESYLATE |
ERIBULIN MESYLATE |
JIANGXI QINGFENG |
|
1MG/2ML (0.5MG/ML) |
SOLUTION;INTRAVENOUS |
No |
No |
RX |
| 2 |
2024-06-28 |
MIDOSTAURIN |
MIDOSTAURIN |
DR REDDYS |
|
25MG |
CAPSULE;ORAL |
No |
No |
RX |
| 3 |
2024-06-28 |
REMIFENTANIL HYDROCHLORIDE |
REMIFENTANIL HYDROCHLORIDE |
NIVAGEN PHARMS INC |
|
EQ 1MG BASE/VIAL |
INJECTABLE;INJECTION |
No |
No |
RX |
| 4 |
2024-06-28 |
REMIFENTANIL HYDROCHLORIDE |
REMIFENTANIL HYDROCHLORIDE |
NIVAGEN PHARMS INC |
|
EQ 2MG BASE/VIAL |
INJECTABLE;INJECTION |
No |
No |
RX |
| 5 |
2024-06-28 |
REMIFENTANIL HYDROCHLORIDE |
REMIFENTANIL HYDROCHLORIDE |
NIVAGEN PHARMS INC |
|
EQ 5MG BASE/VIAL |
INJECTABLE;INJECTION |
No |
No |
RX |
| 6 |
2024-06-28 |
CHEWTADZY |
TADALAFIL |
B BETTER |
|
5MG |
TABLET, CHEWABLE;ORAL |
No |
No |
RX |
| 7 |
2024-06-28 |
PEMETREXED |
PEMETREXED DIPOTASSIUM |
AVYXA HOLDINGS |
|
EQ 500MG BASE/VIAL |
POWDER;INTRAVENOUS |
No |
No |
RX |
| 8 |
2024-06-28 |
PEG-3350, SODIUM SULFATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE, SODIUM ASCORBATE AND ASCORBIC ACID |
ASCORBIC ACID; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM ASCORBATE; SODIUM CHLORIDE; SODIUM SULFATE |
TARO |
|
4.7GM;100GM;1.015GM;5.9GM;2.691GM;7.5GM |
FOR SOLUTION;ORAL |
No |
No |
RX |
| 9 |
2024-06-28 |
CHEWTADZY |
TADALAFIL |
B BETTER |
|
10MG |
TABLET, CHEWABLE;ORAL |
No |
No |
RX |
| 10 |
2024-06-28 |
CHEWTADZY |
TADALAFIL |
B BETTER |
|
20MG |
TABLET, CHEWABLE;ORAL |
No |
No |
RX |